In vivo evidence for the contribution of NOX2 to the innate immunity arsenal was deduced from field observations of high susceptibility of chronic granulomatous disease patients (CGD) to opportunistic pathogens [4], [5]. The gene discussed is CYBB; the disease is chronic granulomatous disease.